University of Bristol Spinout Purespring Therapeutics Launches £80 Million Fund for Kidney Disease…
Purespring Therapeutics has become the first company to successfully treat kidney disease models by directly targeting the podocyte – a specialised cell implicated in approximately 60% of renal diseases.
The company has developed a…